Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

THRX Theseus Pharmaceuticals Inc

0.00 (0.00%)
Pre Market
Last Updated: 20:00:00
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 4.05
Ask Price 3.91
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Theseus Pharmaceuticals Inc THRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 4.06 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 2.05 - 12.37
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 4.06 USD

Theseus Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 179.57M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Theseus Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No THRX Message Board. Create One! See More Posts on THRX Message Board See More Message Board Posts

Historical THRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months4.,939-0.02-0.49%
6 Months2.364.202.053.55736,1241.7072.03%
1 Year9.5512.372.054.07528,847-5.49-57.49%
3 Years20.8024.542.056.44279,412-16.74-80.48%
5 Years20.8024.542.056.44279,412-16.74-80.48%

Theseus Pharmaceuticals Description

Theseus Pharmaceuticals Inc is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's development programs are designed to address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer.

Your Recent History

Delayed Upgrade Clock